Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.30 |
| ▸ | F2R | P25116 | 1/20 | 0.30 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.30 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.30 |
| ▸ | ACACB | O00763 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28148769 | 1.00 | CYP3A4 (0.34) | CYP3A4TSHRSMN1; SMN2NFKB1NPC1 | |
| SCHEMBL28205264 | 1.00 | CYP3A4 (0.34) | CYP3A4TSHRSMN1; SMN2NFKB1NPC1 | |
| SCHEMBL28205825 | 0.88 | BRD4 (0.33) | NPC1 | |
| SCHEMBL28205270 | 0.88 | BRD4 (0.33) | NPC1 | |
| SCHEMBL28205267 | 0.86 | PTGER2 (0.30) | — | |
| SCHEMBL28205831 | 0.85 | PRKCA (0.32) | FFAR1ACACB | |
| SCHEMBL28844839 | 0.83 | PYGL (0.35) | ACACB | |
| SCHEMBL28205269 | 0.81 | NOS3 (0.37) | FFAR1ACACB | |
| SCHEMBL28857371 | 0.81 | LMNA (0.47) | SMN1; SMN2NPC1 | |
| SCHEMBL28149976 | 0.81 | LMNA (0.47) | SMN1; SMN2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105073710-B | Novel hydroxamic acid derivative or salt thereof | 富山化学工业株式会社 | 2018-02-16 | — | — | CN | claimed |
| CN-106794160-A | Pharmaceutical composition containing new hydroxamic acid derivative or its salt | 富山化学工业株式会社 | 2017-05-31 | — | — | CN | claimed |
| CN-106794162-A | Method for combined use of novel hydroxamic acid derivatives and antibacterial substances | 富山化学工业株式会社 | 2017-05-31 | — | — | CN | claimed |
| CN-105073710-B | Novel hydroxamic acid derivative or salt thereof | 富山化学工业株式会社 | 2018-02-16 | — | — | CN | disclosed |
| CN-106794160-A | Pharmaceutical composition containing new hydroxamic acid derivative or its salt | 富山化学工业株式会社 | 2017-05-31 | — | — | CN | disclosed |
| CN-106794162-A | Method for combined use of novel hydroxamic acid derivatives and antibacterial substances | 富山化学工业株式会社 | 2017-05-31 | — | — | CN | disclosed |
| CN-106794162-A | Method for combined use of novel hydroxamic acid derivatives and antibacterial substances | 富山化学工业株式会社 | 2017-05-31 | — | — | CN | disclosed |